27 May 2008 Bavarian Nordic enters clinical trials with HIV multiantigen vaccine
27 May 2008 Favrille Announces Results from Phase 3 Registration Trial of Specifid in Patients with Follicular B-Cell Non-Hodgkin's Lymphoma
19 May 2008 First pre-pandemic vaccine approved to help protect against pandemic influenza
16 May 2008 Dynavax TOLAMBA(TM) Chamber Study Misses Primary Endpoint; Company Updates 2008 Financial Outlook
15 May 2008 Novavax completes enrollment in phase 1/IIa pandemic influenza vaccine clinical trial
14 May 2008 In a Phase II study, Novartis Meningitis B vaccine has potential to produce a protective immune response in infants[1], the age group most at risk
12 May 2008 Nventa announces additional positive immunological data from HSPE7 phase 1 Cervical Dysplasia trial
09 May 2008 Dutch Authorize Manufacture of Vaccinogen’s New Cancer Vaccine
06 May 2008 Novartis Menveo(R) vaccine shows superior immune response against four types of meningitis disease in pivotal phase III trial
30 Apr 2008 Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
29 Apr 2008 DOR BioPharma Initiates Non-Human Primate Efficacy Studies of RiVaxTM, Its Vaccine Against Ricin Toxin
22 Apr 2008 Biovex agrees SPA with the FDA for a pivotal study with ONCOVEXGM-CSF in metastatic melanoma and announces presentation of phase II results at ASCO
17 Apr 2008 Alphavax announces initial analysis of data from CMV phase I clinical trial
17 Apr 2008 Dynavax and Merck & Co., Inc. Update Status of Clinical Hold of Investigational Vaccine HEPLISAV(TM)
16 Apr 2008 Novavax Reports Positive Results from Preclinical Studies of its VLP-based
16 Apr 2008 Pfizer and AVANT Enter into Licensing and Development Agreement for Novel Therapeutic Vaccine Candidate for Brain Cancer
15 Apr 2008 Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch
14 Apr 2008 Cell Genesys Reports Preclinical Data Demonstrating Superior Anti-Tumor Immunity for Multiantigen Compared to Single-Antigen Immunotherapies
11 Apr 2008 Cell Genesys Announces Encouraging Results from Phase 1/2 Trial of GVAX Immunotherapy for Prostate Cancer in Recurrent Disease
10 Apr 2008 Post-exposure vaccination with IMVAMUNE(R) protects against lethal poxvirus infection
09 Apr 2008 Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa
08 Apr 2008 Oncophage(R) Approved in Russia for the Treatment of Intermediate-Risk Kidney Cancer
04 Apr 2008 FDA Approves ROTARIX(R) Rotavirus Vaccine
04 Apr 2008 Prostate Cancer DNA Vaccine Results in Higher T-Cell Response When Delivered via Inovio Biomedical's Electroporation Delivery System
03 Apr 2008 Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up